Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FreshKote vs Systane in Dry Eye
NCT01386073Phase 4Unknown
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2011
- Primary completion
- Nov 2012
- Modality
- Polymer-based Nanoparticles, Implantable Devices
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of polyvinyl alcohol in dry eye syndrome (DED) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Tear Break Up Time at 3 months and Best Corrected Visual Acuity at 3 months. Status: unknown.
02
Drugs
polyvinyl alcohol
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01386073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01386073.